Sera Prognostics, Inc. (SERA) Reports Q4 Loss, Misses Revenue Estimates

Core Viewpoint - Sera Prognostics, Inc. reported a quarterly loss of $0.25 per share, slightly worse than the Zacks Consensus Estimate of a loss of $0.23, indicating a negative earnings surprise of -8.70% [1] Financial Performance - The company posted revenues of $0.02 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 20%, and a decline from $0.04 million in the same quarter last year [2] - Over the last four quarters, Sera Prognostics has consistently failed to meet consensus EPS and revenue estimates [2] Stock Performance - Sera Prognostics shares have declined approximately 49.9% since the beginning of the year, contrasting with the S&P 500's decline of -4.5% [3] - The current Zacks Rank for Sera Prognostics is 4 (Sell), indicating expectations of underperformance in the near future [6] Earnings Outlook - The consensus EPS estimate for the upcoming quarter is -$0.24 on revenues of $0.1 million, and for the current fiscal year, it is -$0.98 on revenues of $3.5 million [7] - The trend of estimate revisions for Sera Prognostics has been unfavorable leading up to the earnings release [6] Industry Context - The Medical Services industry, to which Sera Prognostics belongs, is currently ranked in the top 29% of over 250 Zacks industries, suggesting a relatively strong industry performance [8]